Pharmacodynamics effect of methylprednisolone tablets on the serum concentration of annexin A1: in vivo comparative study between generic and innovator drug
- At January 01, 2019
- By Yori Yuliandra
- In Scientific Paper
0
HANSEN NASIF, HENNY LUCIDA , YANWIRASTI YANWIRASTI, YUFRI ALDI, YORI YULIANDRA
Abstract
Objective: The aims of this study were to investigate the comparative pharmacodynamics effect of methylprednisolone (MP) innovator, MP branded generic, and MP generic products to the serum concentration of annexin A1 (AnxA1).
Methods: It was conducted by two-way crossover design in male rabbits. AnxA1 was measured at 0, 0.5, 1, 2, 3, 5, 7, and 9 h after the administration of the drugs. The peak concentration (Cmax), the time at which the peak concentration was achieved (Tmax), and the area under the plasma concentration-time curve (AUC) were also determined.
Results: The highest concentration and widest AUC of AnxA1 were obtained in MP innovator drug. MP innovator and branded generic reaches the peak time (Tmax) at the third 3rd h, while the MP generic reaches the peak time at the 5th h. The results showed that there was no significant difference in the serum concentration of AnxA1 between MP tablets after analyzed with a one-way analysis of variance.
Conclusion: It could be concluded that the innovator drug of MP tablet gave the same effect on the serum concentration of AnxA1 than its generic counterparts, but an onset of action MP innovator and branded generic is faster than the generic product.
Full paper
Published in Asian J Pharm Clin Res 12(1), 414-417 (Jan 2019)
DOI: 10.22159/ajpcr.2019.v12i1.30010
- ITalk Episode 2: Belajar di Negeri Kangguru dengan Beasiswa - April 20, 2021
- Solid Dispersions of Famotidine: Physicochemical Properties and In Vivo Comparative Study on the Inhibition of Hyperacidity - August 9, 2020
- Menjadi “orang kimia” itu… (Refleksi satu tahun penelitian kimia farmasi) - March 7, 2020
